摘要
目的观察普罗布考对急性脑梗死患者高敏C反应蛋白和血小板功能的影响。方法56例急性脑梗死患者按入院顺序随机分为治疗组和对照组各28例。治疗组在常规治疗的基础上加普罗布考0.5g,2次/d,连续30d,并于治疗前后进行神经功能评估(NIHSS评分)与高敏C反应蛋白和血小板功能测定。结果普罗布考治疗后在神经功能改善的同时,能够降低高敏C反应蛋白并且血小板功能亦得以改善。结论普罗布考具有降低C反应蛋白和改善血小板功能的作用。
Objective To observe the clinical efficacy of probucol and its effect on functions of C-reactive protein and rate of platelet aggregation of patients with aeut cerebral infarction. Methods 56 patients with acute cerebral infarction were equally and randomly divided to control group ( receive routine therapy ) and treatment group ( receive routine therapy plus 0. 5 g probucol, bid, for 30 days). The neurological function (NIHSS) was evaluated and the C-reactive protein and rate of platelet aggregation were measured before and after treatment. Results After treatment, C-reactive protein and rate of platelet aggregation were markedly improved following improvement in neurological function. Conclusion Probucol possesses the effects of reduce C- reactive protein and rate of platelet aggregation.
出处
《中国实用医药》
2009年第8期19-20,共2页
China Practical Medicine
关键词
急性脑梗死
高敏C反应蛋白
普罗布考
血小板
Cerebral infarction
Probucol
C-reactive protein
Rate of platelet aggregation